{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,11]],"date-time":"2026-09-11T05:25:45Z","timestamp":1789104345270,"version":"build-2803163510"},"reference-count":44,"publisher":"Springer Science and Business Media LLC","issue":"12","license":[{"start":{"date-parts":[[2005,6,8]],"date-time":"2005-06-08T00:00:00Z","timestamp":1118188800000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Neuropsychopharmacol"],"published-print":{"date-parts":[[2005,12]]},"DOI":"10.1038\/sj.npp.1300790","type":"journal-article","created":{"date-parts":[[2005,6,15]],"date-time":"2005-06-15T05:58:41Z","timestamp":1118815121000},"page":"2245-2253","source":"Crossref","is-referenced-by-count":74,"title":["Prolonged Central \u03bc-Opioid Receptor Occupancy after Single and Repeated Nalmefene Dosing"],"prefix":"10.1038","volume":"30","author":[{"given":"Kimmo","family":"Ingman","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nora","family":"Hagelberg","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sargo","family":"Aalto","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kjell","family":"N\u00e5gren","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Auni","family":"Juhakoski","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sakari","family":"Karhuvaara","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Antero","family":"Kallio","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Vesa","family":"Oikonen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jarmo","family":"Hietala","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Harry","family":"Scheinin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2005,6,8]]},"reference":[{"key":"BF1300790_CR1","doi-asserted-by":"publisher","first-page":"421","DOI":"10.1097\/01.jcp.0000130555.63254.73","volume":"24","author":"RF Anton","year":"2004","unstructured":"Anton RF, Pettinati H, Zweben A, Kranzler HR, Johnson B, Bohn MJ et al (2004). A multi-site dose ranging study of nalmefene in the treatment of alcohol dependence. J Clin Psychopharmacol 24: 421\u2013428.","journal-title":"J Clin Psychopharmacol"},{"key":"BF1300790_CR2","doi-asserted-by":"publisher","first-page":"1142","DOI":"10.1097\/01.ALC.0000075548.83053.A9","volume":"27","author":"J Balldin","year":"2003","unstructured":"Balldin J, Berglund M, Borg S, Mansson M, Bendtsen P, Franck J et al (2003). A 6-month controlled naltrexone study: combined effect with cognitive behavioral therapy in outpatient treatment of alcohol dependence. Alcohol Clin Exp Res 27: 1142\u20131149.","journal-title":"Alcohol Clin Exp Res"},{"key":"BF1300790_CR3","doi-asserted-by":"publisher","first-page":"255","DOI":"10.1016\/j.biopsych.2003.07.007","volume":"55","author":"B Bencherif","year":"2004","unstructured":"Bencherif B, Wand GS, McCaul ME, Kim YK, Ilgin N, Dannals RF et al (2004). Mu-opioid receptor binding measured by [11C]carfentanil positron emission tomography is related to craving and mood in alcohol dependence. Biol Psychiatry 55: 255\u2013262.","journal-title":"Biol Psychiatry"},{"key":"BF1300790_CR4","doi-asserted-by":"publisher","first-page":"391","DOI":"10.1016\/S0893-133X(02)00302-0","volume":"27","author":"R Ciccocioppo","year":"2002","unstructured":"Ciccocioppo R, Martin-Fardon R, Weiss F (2002). Effect of selective blockade of mu1 or delta opioid receptors on reinstatement of alcohol-seeking behavior by drug-associated stimuli in rats. Neuropsychopharmacology 27: 391\u2013399.","journal-title":"Neuropsychopharmacology"},{"key":"BF1300790_CR5","unstructured":"Committee for Proprietary Medicinal Products (CPMP) and Internation Conference on Harmonisation (ICH) (1995). Good Clinical Practice. CPMP\/ICH\/135\/95."},{"key":"BF1300790_CR6","doi-asserted-by":"publisher","first-page":"1171","DOI":"10.1016\/S0278-5846(99)00060-3","volume":"23","author":"MS Cowen","year":"1999","unstructured":"Cowen MS, Lawrence AJ (1999). The role of opioid\u2013dopamine interactions in the induction and maintenance of ethanol consumption. Prog Neuropsychopharmacol Biol Psychiatry 23: 1171\u20131212.","journal-title":"Prog Neuropsychopharmacol Biol Psychiatry"},{"key":"BF1300790_CR7","doi-asserted-by":"publisher","first-page":"1187","DOI":"10.1016\/0024-3205(95)00057-D","volume":"56","author":"JA Culpepper-Morgan","year":"1995","unstructured":"Culpepper-Morgan JA, Holt PR, LaRoche D, Kreek MJ (1995). Orally administered opioid antagonists reverse both mu and kappa opioid agonist delay of gastrointestinal transit in the guinea pig. Life Sci 56: 1187\u20131192.","journal-title":"Life Sci"},{"key":"BF1300790_CR8","doi-asserted-by":"publisher","first-page":"497","DOI":"10.1016\/0091-3057(90)90019-E","volume":"37","author":"DL DeHaven-Hudkins","year":"1990","unstructured":"DeHaven-Hudkins DL, Brostrom PA, Allen JT, Lesko LJ, Ferkany JW, Kaplita PV et al (1990). Pharmacologic profile of NPC 168 (naltrexone phenyl oxime), a novel compound with activity at opioid receptors. Pharmacol Biochem Behav 37: 497\u2013504.","journal-title":"Pharmacol Biochem Behav"},{"key":"BF1300790_CR9","first-page":"567","volume":"48","author":"BN Dhawan","year":"1996","unstructured":"Dhawan BN, Cesselin F, Raghubir R, Reisine T, Bradley PB, Portoghese PS et al (1996). International Union of Pharmacology. XII. Classification of opioid receptors. Pharmacol Rev 48: 567\u2013592.","journal-title":"Pharmacol Rev"},{"key":"BF1300790_CR10","doi-asserted-by":"publisher","first-page":"233","DOI":"10.1002\/j.1552-4604.1987.tb02191.x","volume":"27","author":"R Dixon","year":"1987","unstructured":"Dixon R, Gentile J, Hsu HB, Hsiao J, Howes J, Garg D et al (1987). Nalmefene: safety and kinetics after single and multiple oral doses of a new opioid antagonist. J Clin Pharmacol 27: 233\u2013239.","journal-title":"J Clin Pharmacol"},{"key":"BF1300790_CR11","doi-asserted-by":"publisher","first-page":"1362","DOI":"10.1097\/01.ALC.0000139704.88862.01","volume":"28","author":"DJ Drobes","year":"2004","unstructured":"Drobes DJ, Anton RF, Thomas SE, Voronin K (2004). Effects of naltrexone and nalmefene on subjective response to alcohol among non-treatment-seeking alcoholics and social drinkers. Alcohol Clin Exp Res 28: 1362\u20131370.","journal-title":"Alcohol Clin Exp Res"},{"key":"BF1300790_CR12","first-page":"1630","volume":"271","author":"PJ Emmerson","year":"1994","unstructured":"Emmerson PJ, Liu MR, Woods JH, Medzihradsky F (1994). Binding affinity and selectivity of opioids at mu, delta and kappa receptors in monkey brain membranes. J Pharmacol Exp Ther 271: 1630\u20131637.","journal-title":"J Pharmacol Exp Ther"},{"key":"BF1300790_CR13","doi-asserted-by":"publisher","first-page":"177","DOI":"10.1016\/S0969-8051(02)00411-0","volume":"30","author":"CJ Endres","year":"2003","unstructured":"Endres CJ, Bencherif B, Hilton J, Madar I, Frost JJ (2003). Quantification of brain \u03bc-opioid receptors with [11C]carfentanil: reference-tissue methods. Nucl Med Biol, 2003 30: 177\u2013186.","journal-title":"Nucl Med Biol"},{"key":"BF1300790_CR14","doi-asserted-by":"publisher","first-page":"537","DOI":"10.1038\/clpt.1986.220","volume":"40","author":"TJ Gal","year":"1986","unstructured":"Gal TJ, DiFazio CA, Dixon R (1986). Prolonged blockade of opioid effect with oral nalmefene. Clin Pharmacol Ther 40: 537\u2013542.","journal-title":"Clin Pharmacol Ther"},{"key":"BF1300790_CR15","doi-asserted-by":"publisher","first-page":"592","DOI":"10.1097\/00004714-200212000-00009","volume":"22","author":"M Gastpar","year":"2002","unstructured":"Gastpar M, Bonnet U, Boning J, Mann K, Schmidt LG, Soyka M et al (2002). Lack of efficacy of naltrexone in the prevention of alcohol relapse: results from a German multicenter study. J Clin Psychopharmacol 22: 592\u2013598.","journal-title":"J Clin Psychopharmacol"},{"key":"BF1300790_CR16","doi-asserted-by":"publisher","first-page":"39","DOI":"10.2174\/1568026043451573","volume":"4","author":"C Gianoulakis","year":"2004","unstructured":"Gianoulakis C (2004). Endogenous opioids and addiction to alcohol and other drugs of abuse. Curr Top Med Chem 4: 39\u201350.","journal-title":"Curr Top Med Chem"},{"key":"BF1300790_CR17","doi-asserted-by":"publisher","first-page":"279","DOI":"10.1006\/nimg.1997.0303","volume":"6","author":"RN Gunn","year":"1997","unstructured":"Gunn RN, Lammertsma AA, Hume SP, Cunningham VJ (1997). Parametric imaging of ligand\u2013receptor binding in PET using a simplified reference region model. Neuroimage 6: 279\u2013287.","journal-title":"Neuroimage"},{"key":"BF1300790_CR18","doi-asserted-by":"publisher","first-page":"99","DOI":"10.1007\/s002130050169","volume":"129","author":"A Herz","year":"1997","unstructured":"Herz A (1997). Endogenous opioid system and alcohol addiction. Psychopharmacology 129: 99\u2013111.","journal-title":"Psychopharmacology"},{"key":"BF1300790_CR19","doi-asserted-by":"publisher","first-page":"438","DOI":"10.3109\/07853899908998802","volume":"31","author":"J Hietala","year":"1999","unstructured":"Hietala J (1999). Ligand\u2013receptor interactions as studied by PET: implications for drug development. Ann Med 31: 438\u2013443.","journal-title":"Ann Med"},{"key":"BF1300790_CR20","doi-asserted-by":"publisher","first-page":"285","DOI":"10.1038\/sj.npp.1300338","volume":"29","author":"HL June","year":"2004","unstructured":"June HL, Cummings R, Eiler WJ II, Foster KL, McKay PF, Seyoum R et al (2004). Central opioid receptors differentially regulate the nalmefene-induced suppression of ethanol- and saccharin-reinforced behaviors in alcohol-preferring (P) rats. Neuropsychopharmacology 29: 285\u2013299.","journal-title":"Neuropsychopharmacology"},{"key":"BF1300790_CR21","first-page":"2174","volume":"22","author":"HL June","year":"1998","unstructured":"June HL, Grey C, Warren-Reese C, Durr LF, Ricks-Cord A, Johnson A et al (1998). The opioid receptor antagonist nalmefene reduces responding maintained by ethanol presentation: preclinical studies in ethanol-preferring and outbred Wistar rats. Alcohol Clin Exp Res 22: 2174\u20132185.","journal-title":"Alcohol Clin Exp Res"},{"key":"BF1300790_CR22","first-page":"161","volume":"25","author":"S Kapur","year":"2000","unstructured":"Kapur S, Seeman P (2000). Antipsychotic agents differ in how fast they come off the dopamine D2 receptors. Implications for atypical antipsychotic action. J Psychiatry Neurosci 25: 161\u2013166.","journal-title":"J Psychiatry Neurosci"},{"key":"BF1300790_CR23","first-page":"1726","volume":"38","author":"S Kim","year":"1997","unstructured":"Kim S, Wagner Jr HN, Villemagne VL, Kao PF, Dannals RF, Ravert HT et al (1997). Longer occupancy of opioid receptors by nalmefene compared to naloxone as measured in vivo by a dual-detector system. J Nucl Med 38: 1726\u20131731.","journal-title":"J Nucl Med"},{"key":"BF1300790_CR24","doi-asserted-by":"publisher","first-page":"177","DOI":"10.1016\/0165-6147(92)90060-J","volume":"13","author":"GF Koob","year":"1992","unstructured":"Koob GF (1992). Drugs of abuse: anatomy, pharmacology and function of reward pathways. Trends Pharmacol Sci 13: 177\u2013184.","journal-title":"Trends Pharmacol Sci"},{"key":"BF1300790_CR25","doi-asserted-by":"publisher","first-page":"493","DOI":"10.1016\/S0893-133X(99)00135-9","volume":"22","author":"HR Kranzler","year":"2000","unstructured":"Kranzler HR, Modesto-Lowe V, Van Kirk J (2000). Naltrexone vs nefazodone for treatment of alcohol dependence. A placebo-controlled trial. Neuropsychopharmacology 22: 493\u2013503.","journal-title":"Neuropsychopharmacology"},{"key":"BF1300790_CR26","doi-asserted-by":"publisher","first-page":"1734","DOI":"10.1056\/NEJMoa011127","volume":"345","author":"JH Krystal","year":"2001","unstructured":"Krystal JH, Cramer JA, Krol WF, Kirk GF, Rosenheck RA (2001). Naltrexone in the treatment of alcohol dependence. N Engl J Med 345: 1734\u20131739.","journal-title":"N Engl J Med"},{"key":"BF1300790_CR27","doi-asserted-by":"publisher","first-page":"153","DOI":"10.1006\/nimg.1996.0066","volume":"4","author":"AA Lammertsma","year":"1996","unstructured":"Lammertsma AA, Hume SP (1996). Simplified reference tissue model for PET receptor studies. Neuroimage 4: 153\u2013158.","journal-title":"Neuroimage"},{"key":"BF1300790_CR28","doi-asserted-by":"publisher","first-page":"1162","DOI":"10.1111\/j.1530-0277.1994.tb00098.x","volume":"18","author":"BJ Mason","year":"1994","unstructured":"Mason BJ, Ritvo EC, Morgan RO, Salvato FR, Goldberg G, Welch B et al (1994). A double-blind, placebo-controlled pilot study to evaluate the efficacy and safety of oral nalmefene HCl for alcohol dependence. Alcohol Clin Exp Res 18: 1162\u20131167.","journal-title":"Alcohol Clin Exp Res"},{"key":"BF1300790_CR29","doi-asserted-by":"publisher","first-page":"719","DOI":"10.1001\/archpsyc.56.8.719","volume":"56","author":"BJ Mason","year":"1999","unstructured":"Mason BJ, Salvato FR, Williams LD, Ritvo EC, Cutler RB (1999). A double-blind, placebo-controlled study of oral nalmefene for alcohol dependence. Arch Gen Psychiatry 56: 719\u2013724.","journal-title":"Arch Gen Psychiatry"},{"key":"BF1300790_CR30","doi-asserted-by":"publisher","first-page":"309","DOI":"10.1124\/jpet.104.072686","volume":"312","author":"JK Melichar","year":"2004","unstructured":"Melichar JK, Hume SP, Williams TM, Daglish MR, Taylor LG, Ahmad R et al (2004). Using [11C]-Diprenorphine to image opioid receptor occupancy by methadone in opioid addiction: clinical and preclinical studies. J Pharmacol Exp Ther 312: 309\u2013315.","journal-title":"J Pharmacol Exp Ther"},{"key":"BF1300790_CR31","first-page":"15","volume":"45","author":"MC Meyer","year":"1984","unstructured":"Meyer MC, Straughn AB, Lo MW, Schary WL, Whitney CC (1984). Bioequivalence, dose-proportionality, and pharmacokinetics of naltrexone after oral administration. J Clin Psychiatry 45: 15\u201319.","journal-title":"J Clin Psychiatry"},{"issue":"Suppl 7","key":"BF1300790_CR32","first-page":"30","volume":"56","author":"SS O'Malley","year":"1995","unstructured":"O'Malley SS (1995). Integration of opioid antagonists and psychosocial therapy in the treatment of narcotic and alcohol dependence. J Clin Psychiatry 56 (Suppl 7): 30\u201338.","journal-title":"J Clin Psychiatry"},{"key":"BF1300790_CR33","doi-asserted-by":"publisher","first-page":"69","DOI":"10.1097\/00004714-200002000-00012","volume":"20","author":"SS O'Malley","year":"2000","unstructured":"O'Malley SS, Krishnan-Sarin S, Farren C, O'Connor PG (2000). Naltrexone-induced nausea in patients treated for alcohol dependence: clinical predictors and evidence for opioid-mediated effects. J Clin Psychopharmacol 20: 69\u201376.","journal-title":"J Clin Psychopharmacol"},{"key":"BF1300790_CR34","doi-asserted-by":"publisher","first-page":"1695","DOI":"10.1001\/archinte.163.14.1695","volume":"163","author":"SS O'Malley","year":"2003","unstructured":"O'Malley SS, Rounsaville BJ, Farren C, Namkoong K, Wu R, Robinson J et al (2003). Initial and maintenance naltrexone treatment for alcohol dependence using primary care vs specialty care: a nested sequence of 3 randomized trials. Arch Intern Med 163: 1695\u20131704.","journal-title":"Arch Intern Med"},{"key":"BF1300790_CR35","doi-asserted-by":"publisher","first-page":"397","DOI":"10.1007\/s002130000666","volume":"154","author":"C Oncken","year":"2001","unstructured":"Oncken C, Van Kirk J, Kranzler HR (2001). Adverse effects of oral naltrexone: analysis of data from two clinical trials. Psychopharmacology (Berl) 154: 397\u2013402.","journal-title":"Psychopharmacology (Berl)"},{"key":"BF1300790_CR36","doi-asserted-by":"publisher","first-page":"339","DOI":"10.1016\/j.physbeh.2004.02.008","volume":"81","author":"LM Oswald","year":"2004","unstructured":"Oswald LM, Wand GS (2004). Opioids and alcoholism. Physiol Behav 81: 339\u2013358.","journal-title":"Physiol Behav"},{"key":"BF1300790_CR37","doi-asserted-by":"publisher","first-page":"876","DOI":"10.1176\/ajp.156.6.876","volume":"156","author":"P Seeman","year":"1999","unstructured":"Seeman P, Tallerico T (1999). Rapid release of antipsychotic drugs from dopamine D2 receptors: an explanation for low receptor occupancy and early clinical relapse upon withdrawal of clozapine or quetiapine. Am J Psychiatry 156: 876\u2013884.","journal-title":"Am J Psychiatry"},{"key":"BF1300790_CR38","doi-asserted-by":"publisher","first-page":"357","DOI":"10.3109\/07853899009147920","volume":"22","author":"JD Sinclair","year":"1990","unstructured":"Sinclair JD (1990). Drugs to decrease alcohol drinking. Ann Med 22: 357\u2013362.","journal-title":"Ann Med"},{"key":"BF1300790_CR39","doi-asserted-by":"publisher","first-page":"595","DOI":"10.1016\/S0969-8051(01)00214-1","volume":"28","author":"M Slifstein","year":"2001","unstructured":"Slifstein M, Laruelle M (2001). Models and methods for derivation of in vivo neuroreceptor parameters with PET and SPECT reversible radiotracers. Nucl Med Biol 28: 595\u2013608.","journal-title":"Nucl Med Biol"},{"key":"BF1300790_CR40","first-page":"CD001867","volume":"2","author":"M Srisurapanont","year":"2002","unstructured":"Srisurapanont M, Jarusuraisin N (2002). Opioid antagonists for alcohol dependence. Cochrane Database Syst Rev 2: CD001867.","journal-title":"Cochrane Database Syst Rev"},{"key":"BF1300790_CR41","doi-asserted-by":"publisher","first-page":"199","DOI":"10.1016\/0014-2999(77)90334-X","volume":"46","author":"KD Stahl","year":"1977","unstructured":"Stahl KD, van Bever W, Janssen P, Simon EJ (1977). Receptor affinity and pharmacological potency of a series of narcotic analgesic, anti-diarrheal and neuroleptic drugs. Eur J Pharmacol 46: 199\u2013205.","journal-title":"Eur J Pharmacol"},{"key":"BF1300790_CR42","doi-asserted-by":"publisher","first-page":"381","DOI":"10.1021\/jm9903702","volume":"43","author":"G Subramanian","year":"2000","unstructured":"Subramanian G, Paterlini MG, Portoghese PS, Ferguson DM (2000). Molecular docking reveals a novel binding site model for fentanyl at the \u03bc-opioid receptor. J Med Chem 43: 381\u2013391.","journal-title":"J Med Chem"},{"key":"BF1300790_CR43","doi-asserted-by":"publisher","first-page":"613","DOI":"10.1176\/ajp.152.4.613","volume":"152","author":"JR Volpicelli","year":"1995","unstructured":"Volpicelli JR, Watson NT, King AC, Sherman CE, O'Brien CP (1995). Effect of naltrexone on alcohol \u2018high\u2019 in alcoholics. Am J Psychiatry 152: 613\u2013615.","journal-title":"Am J Psychiatry"},{"issue":"23","key":"BF1300790_CR44","doi-asserted-by":"publisher","first-page":"3043","DOI":"10.1001\/jama.284.23.3043","volume":"284","author":"Not Available","year":"2000","unstructured":"World Medical Association Declaration of Helsinki. Ethical principles for medical research involving human subjects (2000). JAMA 284: 3043\u20133045.","journal-title":"JAMA"}],"container-title":["Neuropsychopharmacology"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/www.nature.com\/articles\/1300790.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/www.nature.com\/articles\/1300790","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/www.nature.com\/articles\/1300790.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,5,16]],"date-time":"2023-05-16T06:49:08Z","timestamp":1684219748000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/1300790"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2005,6,8]]},"references-count":44,"journal-issue":{"issue":"12","published-print":{"date-parts":[[2005,12]]}},"alternative-id":["BF1300790"],"URL":"https:\/\/doi.org\/10.1038\/sj.npp.1300790","relation":{},"ISSN":["0893-133X","1740-634X"],"issn-type":[{"value":"0893-133X","type":"print"},{"value":"1740-634X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2005,6,8]]}}}